3Sekelj S,Dekaris I,Kondza-Krstonijevi E,et al.Ultraviolet light and pterygium.Coll Antropol 2007;31(Suppl1):45-47.
4Chaidaroon W,Pongmoragot N.Basic tear secretion measurement in pterygium.J Med Assoc Thai 2003;86(4):348-352.
5Zhou L,Beuerman RW,Ang LP,et al.Elevation of human{alpha}defensins and S100calcium binding protein A8and A9in tear fluid of pterygium patients.Invest Ophthalmol Vi.
6Tong L,Li J,Chew J,et al.Phospholipase D in the human ocular surface and in pterygium.Cornea2008;27(6):693-698.
7Mauro J,Foster CS.Pterygia:pathogenesis and the role of subconjunctival bevacizumab in treatment.Semin Ophthalmol2009;24(3):130-134.
8Spandidos DA,Sourvinos G,Kiaris H,et al.Microsatellite instability and loss of heterozygo sity in human pterygia.Br J Ophthalmol 1997;81(6):493-496.
9Tan DT,Lim AS,Goh HS,et al.Abnormal expression of the p53tumor suppressor gene in the conjunctiva of patients with pterygium.Am J Ophthalmol 1997;123(3):404-405.
10Tan DT,TangWY,Liu YP,et al.Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium.Br J Ophthalmol2000;84(2):212-216.
